TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · Real-Time Price · USD
0.660
+0.001 (0.15%)
At close: Dec 20, 2024, 4:00 PM
0.650
-0.010 (-1.52%)
After-hours: Dec 20, 2024, 7:51 PM EST
TC Biopharm (Holdings) Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
361.73K USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 3.84M | 1.87M | 94.30% |
Dec 31, 2021 | 1.98M | - | - |
Dec 31, 2020 | 1.98M | -1.45M | -42.26% |
Dec 31, 2019 | 3.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTCBP News
- 1 day ago - TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients - PRNewsWire
- 3 days ago - TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend - PRNewsWire
- 3 days ago - EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend - Benzinga
- 10 days ago - TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - PRNewsWire
- 17 days ago - TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial - PRNewsWire
- 5 weeks ago - TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant - PRNewsWire
- 7 weeks ago - TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements - PRNewsWire
- 2 months ago - TCBP Responds to False Social Media Claim - PRNewsWire